Jonas W. Wastesson

1 month ago | onlinelibrary.wiley.com | Máté Szilcz |Jonas W. Wastesson |David Bergman |Kristina Johnell

We thank Drs. Tome and Pardi for their editorial on our study examining the association between antibiotic exposure and microscopic colitis (MC) [1]. We appreciate their careful literature review and insightful discussion regarding potential confounding factors that may influence the observed relationship between drug exposures and MC.

2 months ago | onlinelibrary.wiley.com | Máté Szilcz |Jonas W. Wastesson |David Bergman |Kristina Johnell

1 Introduction Microscopic colitis (MC) is a chronic inflammatory condition of the colon that predominantly affects older adults [1]. The condition is characterised by watery, non-bloody diarrhoea, which may significantly worsen the quality of life [2, 3]. Concerns about drug-induced MC have emerged [4, 5], prompting pharmacoepidemiologic studies on the subject [6].

Jun 20, 2024 | thelancet.com | Bowen Tang |Arvid Sjölander |Jonas W. Wastesson

9Hernán M.A. Robins J.M. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 183: 758-764 The trial emulation is specified in We used the framework proposed by Hernán and Robins to simulate a three-arm RCT comparing the dementia risk among GLP-1 agonist, DPP-4 inhibitor, and sulfonylurea initiators.Table 1.